🇺🇸 Aspirin and Clopidogrel in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Anaemia — 1 report (10%)
- Anaphylactic Shock — 1 report (10%)
- Angioedema — 1 report (10%)
- Back Pain — 1 report (10%)
- Brain Death — 1 report (10%)
- Cardio-Respiratory Arrest — 1 report (10%)
- Drug-Induced Liver Injury — 1 report (10%)
- Ecchymosis — 1 report (10%)
- Encephalopathy — 1 report (10%)
- Epistaxis — 1 report (10%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Aspirin and Clopidogrel approved in United States?
Aspirin and Clopidogrel does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Aspirin and Clopidogrel in United States?
Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.